Phe(576) plays an important role in the secondary structure and intracellular signaling of the human luteinizing hormone chorionic gonadotropin receptor

被引:8
|
作者
Yano, K
Kohn, LD
Saji, M
Okuno, A
Cutler, GB
机构
[1] NIDDKD, CELL REGULAT SECT, METAB DIS BRANCH, NIH, BETHESDA, MD 20892 USA
[2] NICHHD, DEV ENDOCRINOL BRANCH, NIH, BETHESDA, MD 20892 USA
[3] JOHNS HOPKINS UNIV, DEPT SURG, BALTIMORE, MD 21205 USA
来源
关键词
D O I
10.1210/jc.82.8.2586
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent studies have identified multiple activating mutations in the sixth transmembrane domain of LH/chorionic gonadotropin receptor (LH-CGR) in patients with male-limited precocious puberty. Computer analysis suggested that these mutations had an effect on the secondary structure of the third cytoplasmic loop and sixth transmembrane domain, and that Phe(576) was a critical conformational bridging residue between these regions that might be important for receptor activity. We made four amino acid substitutions of the Phe(576) (F576I, F576G, F576Y, F576E) in the LH/CG receptor to analyze its functional role. Computer analysis of secondary structure predicted that the F576E mutant changed the secondary structure to a totally helical conformation in the region of the third intracellular and sixth transmembrane domain. In contrast, the F576G, F576I, and F576Y mutants were predicted to change the helical conformation in the legion to an extended conformation. In expression studies, mutations of Phe(576) produced functional changes in cAMP and inositol phosphate (IP) signaling, and human CG (hCG) binding. Mutations predicted to cause an extended conformation exhibited two functional patterns: first, constitutively activating in cAMP signaling without changes in IP signaling or hCG binding (F576I and F576G), and second, constitutively activating in cAMP signaling with decreased hCG-induced cAMP and IP signaling and with both higher affinity and lower capacity of hCG binding (F576Y). The mutation predicted to cause a totally helical conformation resulted in no cAMP response and a minimal IP response to hCG stimulation, with negligible hCG binding (F576E). These data suggest that the common change induced by the F576I, F576G, and F576Y mutations to an extended conformation on the third cytoplasmic loop and sixth transmembrane domain of the LH/CGR results in increased Gs coupling and activation of adenylyl cyclase, The F576Y mutation appears to have an additional effect, beyond a modification in receptor conformation, that lends to higher affinity and lower capacity of hCG binding, as well as altered Gq coupling and phospholipase C activation The F576E mutation has a distinct and different impact on receptor conformation, which leads to negligible hCG binding and minimal function; however, the F576E mutation may provide a clue to understanding the receptor mutations that result in loss of function and pseudohermaphroditism. We conclude that Phe(576) plays an important role in the human LH/CGR with respect to receptor conformation, Gs coupling, and cAMP signaling consistent with predictions from mutations associated with male-limited precocious puberty.
引用
收藏
页码:2586 / 2591
页数:6
相关论文
共 50 条
  • [41] IDENTIFICATION OF HORMONE-BINDING REGIONS OF THE LUTEINIZING-HORMONE HUMAN CHORIONIC-GONADOTROPIN RECEPTOR USING SYNTHETIC PEPTIDES
    ROCHE, PC
    RYAN, RJ
    MCCORMICK, DJ
    ENDOCRINOLOGY, 1992, 131 (01) : 268 - 274
  • [42] Luteinizing Hormone/Human Chorionic Gonadotropin Receptor Immunohistochemical Score Associated with Poor Prognosis in Endometrial Cancer Patients
    Sorbi, Flavia
    Projetto, Elisabetta
    Turrini, Irene
    Baroni, Gianna
    Pillozzi, Serena
    Ghizzoni, Viola
    Vergoni, Federica
    Castiglione, Francesca
    Malentacchi, Francesca
    Fambrini, Massimiliano
    Noci, Ivo
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [43] MULTIPLE INHIBITORY ACTIONS OF LUTEINIZING-HORMONE-RELEASING HORMONE AGONIST ON LUTEINIZING-HORMONE HUMAN CHORIONIC-GONADOTROPIN RECEPTOR-MEDIATED OVARIAN RESPONSES
    REDDY, PV
    AZHAR, S
    MENON, KMJ
    ENDOCRINOLOGY, 1980, 107 (04) : 930 - 936
  • [44] ROLE OF THYROID-HORMONE IN CONTROLLING THE CONCENTRATION OF LUTEINIZING-HORMONE HUMAN CHORIONIC-GONADOTROPIN RECEPTORS IN RAT OVARIES
    FITKO, R
    SZLEZYNGIER, B
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1994, 130 (04) : 378 - 380
  • [45] Hormonal regulation of luteinizing hormone human chorionic gonadotropin receptor mRNA levels in human fallopian tube epithelial cells.
    Han, SW
    Lei, ZM
    Rao, CV
    BIOLOGY OF REPRODUCTION, 1998, 58 : 199 - 199
  • [46] SUBUNIT INTERACTION OF HUMAN CHORIONIC-GONADOTROPIN (HCG) WITH RAT OVARIAN LUTEINIZING-HORMONE (LH) CG RECEPTOR
    PETAJAREPO, UE
    RAJANIEMI, HJ
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1990, 72 (01) : 43 - 53
  • [47] LYMPHOCYTES FROM PREGNANT-WOMEN EXPRESS HUMAN CHORIONIC-GONADOTROPIN LUTEINIZING-HORMONE RECEPTOR GENE
    LIN, J
    LOJUN, S
    LEI, ZM
    WU, WX
    PEINER, SC
    RAO, CV
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1995, 111 (01) : R13 - R17
  • [48] SIGNIFICANCE OF THE GLYCAN MOIETY OF THE RAT OVARIAN LUTEINIZING-HORMONE CHORIONIC-GONADOTROPIN (CG) RECEPTOR AND HUMAN CG FOR RECEPTOR-HORMONE INTERACTION
    PETAJAREPO, UE
    MERZ, WE
    RAJANIEMI, HJ
    ENDOCRINOLOGY, 1991, 128 (03) : 1209 - 1217
  • [49] NOVEL EXPRESSION OF LUTEINIZING-HORMONE (LH) HUMAN CHORIONIC-GONADOTROPIN (HCG) RECEPTOR GENE IN RAT EPIDIDYMIS
    TAO, YX
    LEI, ZM
    RAO, CV
    BIOLOGY OF REPRODUCTION, 1995, 52 : 141 - 141
  • [50] Specificity of heterotrimeric G protein regulation by human chorionic gonadotropin and low-molecular agonist of luteinizing hormone receptor
    Derkach K.V.
    Bakhtyukov A.A.
    Shpakov A.A.
    Dar’in D.V.
    Shpakov A.O.
    Cell and Tissue Biology, 2017, 11 (6) : 475 - 482